Equinor ASA: Notice of annual general meeting 12 May 2026The annual general meeting of Equinor ASA (OSE: EQNR, NYSE: EQNR) will be held Tuesday 12 May 2026 at 15:00 CEST.
Vitaquest Highlights Quality Systems Supporting Its Responsibility to Customers and ConsumersVitaquest outlines quality, packaging, and compliance systems supporting product quality and performance across dietary supplement manufacturing operations
USA Rare Earth Announces Definitive Agreement to Acquire Serra Verde Group for ~$2.8 Billion, Creating the Global Rare Earth LeaderSecures One of the Industry’s Most Strategic Operations as the Only Scaled Producer of all Four Magnetic Rare Earth Elements Outside Asia, along with a 15-Year 100% Offtake Agreement with a Special Purpose Vehicle Capitalized by Various U.S. Government Parties, as well as Private Capital Sources and Including Specific Price Floors for Nd, Pr, Dy and Tb
Biodesix to Report First Quarter 2026 Financial Results on May 4, 2026LOUISVILLE, Colo., April 20, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, today announced that it will release financial results for the first quarter ended March 31, 2026 after the close of trading on Monday, May 4. Biodesix management will host a conference call and webcast to discuss its financial results and provide a general business update at 4:30 p.m. Eastern Time on the same day.
Perspective Therapeutics Presents Updated Interim Data of [212Pb]VMT-α-NET in Its Ongoing Phase 1/2a Clinical Trial at the 2026 AACR Annual MeetingSEATTLE, April 20, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or the “Company) (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body, today announced updated interim results from its ongoing Phase 1/2a clinical trial of [212Pb]VMT-α-NET in patients with unresectable or metastatic somatostatin receptor type 2 (SSTR2) expressing neuroendocrine tumors (NETs) as part of a poster presentation at the American Association for Cancer Research (AACR) Annual Meeting 2026. [212Pb]VMT-α-NET is potentially the first-in-class 212Pb-radiopharmaceutical therapy targeting SSTR2.
"Splendid Jiangsu" Shines in Hong Kong and Macao, Opening a New Chapter of Cultural Exchange and Industrial IntegrationNANJING, China, April 20, 2026 (GLOBE NEWSWIRE) -- To further promote the alignment of cultural industry resources and deepen cooperation between Jiangsu and Hong Kong and Macao, the "Splendid Jiangsu Cultural Exchange and Industrial Promotion Event" was successfully held in Hong Kong and Macao from April 14 to 18.
Copenhagen Infrastructure Partners commences construction on 1,500 MWh BESS project in ChileProject Patache will be Copenhagen Infrastructure Partners’ second large-scale battery energy storage system (BESS) in Chile, reinforcing CIP’s commitment to delivering critical new energy infrastructure across Latin America
Yachting: Yacht Club de Monaco Expands SEA Index Network with Marseille Fos PartnershipMONACO, April 20, 2026 (GLOBE NEWSWIRE) -- The Port de Marseille Fos is stepping up its environmental transition in the maritime sector through a new partnership with the Superyacht Eco Association (SEA Index®), a move that positions the French hub among the most active Mediterranean ports in promoting lower-impact superyacht traffic.
WeRide’s WRD 3.0 Makes History as the Only Four‑Time Champion at China Urban Intelligent Driving CompetitionWUHU, China, April 20, 2026 (GLOBE NEWSWIRE) -- At the Wuhu round of the Second China Urban Intelligent Driving Competition hosted by D1EV, a leading media platform in the electric and intelligent vehicle sector, the Chery Exeed Sterra ET – equipped with the one‑stage end‑to‑end ADAS (Advanced Driver Assistance System) solution jointly developed by WeRide and Bosch – secured first place by over 10 points, with Horizon Robotics and XPeng taking second and third place.
Nearly Half of Consumers Say Their Favorite Restaurant Chain Has Changed in The Last Year, According to New ReportTillster’s eighth annual consumer sentiment report reveals a breakdown in loyalty as diners re-evaluate what influences their dining decisions
Fortuna Establishes Presence in the Guyana Shield Through Quartzstone Earn-In AgreementVANCOUVER, British Columbia, April 20, 2026 (GLOBE NEWSWIRE) -- Fortuna Mining Corp. (NYSE: FSM | TSX: FVI) is pleased to announce it has entered into an earn-in agreement with Qstone Inc., a private Guyanese company, pursuant to which Fortuna may earn up to a 70% interest in the Quartzstone Project, a large land package comprising 29,600 hectares located in the greenstone belt of north central Guyana.
Bombardier and Vista Sign Service Agreement Focused on Smart Parts ProgramsMONTRÉAL, April 20, 2026 (GLOBE NEWSWIRE) -- Bombardier and Vista today announced a long-term services agreement focused on Bombardier’s Smart Parts programs for the aviation company’s recent order of Challenger 3500 aircraft and a large portion of its existing fleet(1). The bespoke agreement will provide Vista with an essential cost-per-flight hour framework to maximize convenience and cost protection for parts.
Supplemental Update Regarding the Board’s Current Pricing Approach for Future M&A-Related Share IssuancesNEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Allied Gaming & Entertainment Inc. (NASDAQ: AGAE, “Allied” or the “Company”) today issued the following supplemental update regarding the Board of Directors’ current pricing approach for any potential future issuance of equity securities in connection with mergers, acquisitions, asset integrations, or similar strategic transactions.
Oculis Announces Completion of Last Patient Visit in Phase 3 DIAMOND Program with OCS-01 Eye Drops for the Treatment of Diabetic Macular EdemaZUG, Switzerland, April 20, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (Oculis), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in ophthalmology and neuro-ophthalmology, today announced completion of the final patient visit in the OCS-01 Phase 3 DIAMOND program in diabetic macular edema (DME). Oculis expects to report topline results in June 2026.
Niu Technologies to Report First Quarter 2026 Financial Results on May 18, 2026BEIJING, April 20, 2026 (GLOBE NEWSWIRE) -- Niu Technologies (“NIU” or “the Company”) (
NASDAQ: NIU), the world’s leading provider of smart urban mobility solutions, today announced that it will report its financial results for the first quarter 2026 before the U.S. market opens on Monday, May 18, 2026.
Resilinc’s Agentic Factory for Operational Supply Chain Resilience at Hannover Messe 2026Exhibiting with Microsoft, Featuring Live Demo on Agentic AI for Supply Chain Disruption Management and Compliance
Swedish Goverment Holds Decision on Norra Karr Exploitation Concession; Directors Exercise Options Injecting New Capital; Investor Relations EngagementSWEDISH GOVERNMENT HOLDS DECISION ON NORRA KÄRR EXPLOITATION CONCESSION; DIRECTORS EXERCISE OPTIONS INJECTING NEW CAPITAL; INVESTOR RELATIONS ENGAGEMENT
Tencent Invests in Kaspi.kz Alongside Co-Founder & CEO Mikheil Lomtadze and Long-Term U.S. Institutional InvestorsALMATY, Kazakhstan, April 20, 2026 (GLOBE NEWSWIRE) -- Kaspi.kz (Nasdaq: KSPI) today announced that Tencent, Kaspi.kz Co-Founder and CEO Mikheil Lomtadze, key members of the senior management team, and long-term institutional investors have completed the purchase of 6.0 million American Depositary Shares (ADSs) from Baring Fintech Venture Funds (the “Funds”).
Schneider Electric and Deloitte collaborate to drive AI-enabled digital transformation across industrial operationsHANNOVER, Germany, April 20, 2026 (GLOBE NEWSWIRE) -- Schneider Electric, a global energy technology leader, and Deloitte, a leading professional services organization, today announced a collaboration to help customers and clients — from manufacturers and industrial operators to data center and infrastructure leaders — modernize end-to-end processes across all of their business operations and unlock new opportunities.
Duncan Brand Announces Release of “Mind the Gap,” Addressing Gaps in Leadership Development PracticesMill Creek, WA, April 19, 2026 (GLOBE NEWSWIRE) -- Duncan Brand, founder of Intrinsic Leader, LLC, has announced the release of his new book, Mind the Gap, which examines challenges in current leadership development practices and outlines approaches organizations can consider to build leadership capability.
SQRIL Expands to Africa with Launch of Stablecoin-to-Fiat QR Payments and Mobile Money Integration in Tanzania, Kenya, and South AfricaSINGAPORE, April 19, 2026 (GLOBE NEWSWIRE) -- SQRIL, the leading cross-border QR code payment infrastructure for emerging markets, today announced its official expansion into Africa. Starting today, SQRIL’s API enables users to perform seamless stablecoin-to-fiat QR code transactions across Tanzania, Kenya, and South Africa, marking a major leap in financial interoperability for the continent.
Monopar Presents Phase 3 Data Showing Greater Neurologic Benefit with ALXN1840 vs SoC in Wilson Disease Patients with Neurologic Symptoms at AAN 2026WILMETTE, Ill., April 19, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, announced new analyses from the randomized controlled Phase 3 FoCus trial of ALXN1840 (tiomolibdate choline, TMC) showing greater neurologic benefit versus standard of care (SoC) in Wilson disease patients with neurologic symptoms at baseline. The data will be presented today at the American Academy of Neurology (AAN) Annual Meeting 2026, taking place April 18-22, 2026.
Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual MeetingVANCOUVER, British Columbia and BOSTON, MA, April 19, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, today presented positive data from the Phase 3 X-TOLE2 study highlighting the efficacy and safety of azetukalner in focal onset seizures (FOS) at the American Academy of Neurology (AAN) Annual Meeting, taking place April 18-22, 2026 in Chicago, Illinois. Xenon is also presenting data at the AAN meeting that reinforce the significant opportunity for azetukalner in epilepsy, including 48-month data from the ongoing X-TOLE open-label extension (OLE) study, as well as real-world data reinforcing the potential value that no-titration options like azetukalner would bring to epilepsy management. Azetukalner (AZK) is a novel, potent, KV7 potassium channel opener currently in clinical development for epilepsy and depression.
KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanomaKIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma
UnifyDrive to Showcase Full NAS Lineup and Debut PixelMob Creator's Companion Prototype at NAB Show 2026Live demonstrations of PixelMob’s six-layer verified backup workflow will run throughout the show alongside hands-on access to all four UnifyDrive products
Molecular Partners presents three posters at AACR 2026, with new preclinical data for first Switch-DARPin T cell engager MP0632 and DLL3 Radio-DARPin MP0712ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass, April 19, 2026 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today announced the presentation of new preclinical data across three posters at the American Association for Cancer Research (AACR) Annual Meeting 2026.
Challenge accepted: Schneider Electric helps industry turn toughest problems into competitive advantageHANNOVER, Germany, April 19, 2026 (GLOBE NEWSWIRE) -- Industrial operations are under pressure from every direction. Energy costs are rising. Legacy systems are holding back progress. The talent pipeline is thinning. And the window to act is narrowing. At Hannover Messe 2026 (20–24 April, Hall 13, Booth C34), Schneider Electric, a global energy technology leader, is showing what it looks like when those problems finally meet their match.
MAPS Welcomes Federal Action to Advance Science-Driven Psychedelic Research and PolicyWASHINGTON, April 18, 2026 (GLOBE NEWSWIRE) -- The Multidisciplinary Association for Psychedelic Studies (MAPS) issued the following statements from Co-Executive Directors Betty Aldworth and Ismail L. Ali, J.D., on today’s Executive Order regarding accelerating research and investment of $50 million of federal funds into studying psychedelic compounds such as ibogaine, psilocybin, LSD, and MDMA.
Bragar Eagel & Squire, P.C. Reminds Eos Energy Enterprises, Inc. (NASDAQ:EOSE) Investors to Contact the Firm Regarding Their Rights Before May 5thBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Eos (EOSE) To Contact Him Directly To Discuss Their Options
Super Stars, Super Heroes and Their Alter Egos Are the Focus of Final Upper Deck DC X NHL® Crossover“Secret Identity” trading card set featuring 12 players and special achievement card available now exclusively on Upper Deck e-Pack®
Other World Computing (OWC) Launches MacDrive 12 at NAB 2026 – One Solution for Complete Mac Disk Access on Windows - Including Native Encrypted APFS SupportNo Conversions, No Cloud Uploads, No Workarounds – Just Complete Drive Sharing Including Encryption with Seamless Access to Every Mac Format Directly in Windows Explorer
Other World Computing Launches OWC Express 4M2 Ultra at NAB 2026 – Thunderbolt 5 Four-Slot NVMe M.2 SSD EnclosureBuilt for Professionals Seeking the Fastest DIY RAID Performance in a Compact Design – To Be Showcased Live for the First Time at NAB 2026 Show, OWC Booth #N2373 (North Hall)
2026 Fujian Provincial Conference on Development of Cultural, Tourism Economy opens on Apr. 17 in Zhangzhou, SE China's FujianZHANGZHOU, China, April 18, 2026 (GLOBE NEWSWIRE) -- The 2026 Fujian Provincial Conference on the Development of Cultural and Tourism Economy kicked off in Zhangzhou, China's Fujian province on Friday. The event is themed "Building a World-Class Destination, Cultivating a Pillar Industry," highlighting elements of Minnan (Southern Fujian) wisdom, lifestyle, and culture. Coinciding with a local major initiative to build the World Minnan Cultural Exchange Center, the conference has curated 6 main activities with 60 peripheral events to attract global visitors.
RedCloud Holdings Plc Receives Notice Regarding Minimum Bid Price RequirementOrdinary shares will continue to trade on the Nasdaq Capital Market, and the Company’s listing on such exchange is not affected by the receipt of the Notice
Abe Safa Expands Market Presence Across Myrtle Beach Real Estate MarketMyrtle Beach, SC, April 17, 2026 (GLOBE NEWSWIRE) -- Abe Safa, a licensed real estate agent with Century 21 The Harrelson Group, expands his market presence across the Myrtle Beach real estate and Grand Strand real estate market, with continued activity serving both buyers and sellers across homes, condos, and investment properties.
Statement from American AirlinesFORT WORTH, Texas, April 17, 2026 (GLOBE NEWSWIRE) -- American Airlines Group Inc. (
NASDAQ: AAL) today issued the following statement:
Fervo Energy Publicly Announces Filing of Registration Statement for Proposed Initial Public OfferingHOUSTON, April 17, 2026 (GLOBE NEWSWIRE) -- Fervo Energy today announced it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the "SEC") relating to the proposed initial public offering of its Class A common stock. The company has applied to list its Class A common stock on the Nasdaq under the ticker symbol “FRVO”.
Result of Voting for Directors at Annual Shareholders’ MeetingTORONTO, April 17, 2026 (GLOBE NEWSWIRE) -- Fairfax Financial Holdings Limited (TSX: FFH and FFH.U) (“Fairfax”) is pleased to announce the results of the vote on Directors at its April 16, 2026 Annual Shareholders’ Meeting.
Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual MeetingFindings support the ongoing Phase 1 clinical development of BBI-940, an oral, selective kinesin degrader, as a potential first-in-class therapy for select advanced or metastatic breast cancers
Sysco Declares Increase to Quarterly Dividend PaymentHOUSTON, April 17, 2026 (GLOBE NEWSWIRE) -- Sysco Corporation (
NYSE:SYY) today announced that its Board of Directors declared a quarterly cash dividend of $0.55 per share, representing a $0.01 increase from the prior quarterly dividend of $0.54 per share. The new dividend is payable for the first time on July 24, 2026, to common stockholders of record at the close of business on July 2, 2026.
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)WALTHAM, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative therapies for patients living with autoimmune diseases, today announced that on April 15, 2026 (the “Grant Date”), the Compensation Committee of the Company’s Board of Directors granted an aggregate of 41,475 restricted stock units of the Company’s common stock (“RSUs”) to newly hired employees of the Company as an inducement material to such employees’ entry into employment with the Company, in accordance with Nasdaq Listing Rule 5635(c)(4) (the “Inducement Grant”).
